Kit for global RNP profiling

Information

  • Research Project
  • 8453115
  • ApplicationId
    8453115
  • Core Project Number
    R43GM105087
  • Full Project Number
    1R43GM105087-01
  • Serial Number
    105087
  • FOA Number
    PA-12-088
  • Sub Project Id
  • Project Start Date
    5/1/2013 - 12 years ago
  • Project End Date
    10/31/2013 - 11 years ago
  • Program Officer Name
    MAAS, STEFAN
  • Budget Start Date
    5/1/2013 - 12 years ago
  • Budget End Date
    10/31/2013 - 11 years ago
  • Fiscal Year
    2013
  • Support Year
    01
  • Suffix
  • Award Notice Date
    4/15/2013 - 12 years ago

Kit for global RNP profiling

DESCRIPTION (provided by applicant): RNAs and ribonucleoprotein complexes (RNPs) play central roles in biology and disease. Despite their importance to both basic and clinical biology, there is no general methodology to study the composition and function of RNPs isolated from their native context. To address this need, our Phase I goal is to develop a new and robust affinity separation technology for RNP complexes. In Phase II, we propose to develop the method into an easy-to-use kit that can be employed by researchers to detect and analyze specific RNPs in their laboratories without special expertise for a variety of applications. Our strategy is based on an endoribonuclease that binds a specific RNA sequence with very high affinity and cleaves this sequence at a single site. A mutant version of this protein can bind but not cleave target RNA. In our method, a target RNA will be expressed in vitro or in vivo with a 5' tag composed of the endoribonuclease target sequence. Cellular extracts will be applied to the mutant endoribonuclease immobilized on resin. The tagged RNA will be trapped by the mutant endoribonuclease. Under specific buffer conditions, cleavage activity of the mutant endoribonuclease can be reactivated, causing the tag to be cleaved off, liberating the target RNA and any protein partners bound to it. The isolated RNA and its associated RNA binding proteins can then be analyzed by a variety of molecular biological or biophysical techniques.

IC Name
NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES
  • Activity
    R43
  • Administering IC
    GM
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    158902
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    859
  • Ed Inst. Type
  • Funding ICs
    NIGMS:158902\
  • Funding Mechanism
    SBIR-STTR RPGs
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    CARIBOU BIOSCIENCES, INC.
  • Organization Department
  • Organization DUNS
    078282991
  • Organization City
    BERKELEY
  • Organization State
    CA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    947102753
  • Organization District
    UNITED STATES